Of note, IL-6 had a different pattern from most other neuroinflammatory markers in our cohort; increased IL-6 correlated with less AD pathology, neurodegeneration, and synaptic loss, however, there were no differences between the clinical groups. This evidence concerns the gene IL6 and Alzheimer disease.